Anchor Capital Advisors’s Pfizer PFE Stock Holding History

Anchor Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,394	Closed	-$238K	–	245
2025 Q1	$238K	Sell	9,394 -310	-3%	-$8.11K	0.01%	233
2024 Q4	$257K	Sell	9,704 -1,892	-16%	-$51.3K	0.01%	229
2024 Q3	$336K	Sell	11,596 -2,870	-20%	-$83.7K	0.01%	217
2024 Q2	$405K	Sell	14,466 -840	-5%	-$23.1K	0.01%	205
2024 Q1	$425K	Sell	15,306 -5,665	-27%	-$157K	0.01%	208
2023 Q4	$604K	Sell	20,971 -1,780	-8%	-$53.8K	0.02%	197
2023 Q3	$755K	Sell	22,751 -150	-0.7%	-$5.3K	0.02%	181
2023 Q2	$840K	Sell	22,901 -1,480	-6%	-$57.6K	0.02%	188
2023 Q1	$995K	Sell	24,381 -980	-4%	-$42.3K	0.03%	167
2022 Q4	$1.3M	Sell	25,361 -5	-0%	-$240	0.03%	150
2022 Q3	$1.11M	Sell	25,366 -190	-0.7%	-$9.23K	0.03%	163
2022 Q2	$1.34M	Sell	25,556 -4,085	-14%	-$208K	0.03%	153
2022 Q1	$1.53M	Sell	29,641 -2,060	-6%	-$107K	0.03%	163
2021 Q4	$1.87M	Sell	31,701 -1,725	-5%	-$85.5K	0.04%	150
2021 Q3	$1.44M	Sell	33,426 -1,484	-4%	-$65.7K	0.03%	160
2021 Q2	$1.37M	Sell	34,910 -389,251	-92%	-$15.1M	0.03%	170
2021 Q1	$15.4M	Buy	424,161 +21,013	+5%	+$746K	0.32%	97
2020 Q4	$14.8M	Sell	403,148 -20,558	-5%	-$754K	0.34%	96
2020 Q3	$14.8M	Buy	423,706 +6,581	+2%	+$231K	0.37%	93
2020 Q2	$12.9M	Sell	417,125 -6,660	-2%	-$226K	0.33%	100
2020 Q1	$13.1M	Sell	423,785 -11,708	-3%	-$399K	0.39%	89
2019 Q4	$16.2M	Buy	435,493 +48,895	+13%	+$1.74M	0.35%	93
2019 Q3	$13.2M	Sell	386,598 -60,145	-13%	-$2.19M	0.48%	87
2019 Q2	$18.4M	Sell	446,743 -266,773	-37%	-$10.6M	0.66%	70
2019 Q1	$28.8K	Sell	713,516 -41,600	-6%	-$1.67M	0.61%	34
2018 Q4	$31.3M	Sell	755,116 -13,012	-2%	-$540K	1.27%	20
2018 Q3	$32.1M	Sell	768,128 -26,507	-3%	-$1.02M	1.17%	27
2018 Q2	$27.4M	Sell	794,635 -67,056	-8%	-$2.29M	1%	32
2018 Q1	$29M	Buy	861,691 +47,606	+6%	+$1.64M	1.01%	30
2017 Q4	$28M	Buy	814,085 +1,867	+0.2%	+$63.7K	0.99%	37
2017 Q3	$27.5M	Sell	812,218 -14,000	-2%	-$450K	0.99%	37
2017 Q2	$26.3M	Sell	826,218 -21,638	-3%	-$682K	0.96%	35
2017 Q1	$27.5M	Sell	847,856 -4,180	-0.5%	-$132K	0.96%	41
2016 Q4	$26.3M	Buy	852,036 +46,264	+6%	+$1.41M	1%	41
2016 Q3	$25.9M	Sell	805,772 -223,419	-22%	-$7.47M	0.87%	43
2016 Q2	$34.4M	Sell	1,029,191 -69,073	-6%	-$2.2M	0.87%	47
2016 Q1	$30.9M	Buy	1,098,264 +1,085,702	+8,643%	+$31M	0.74%	56
2015 Q4	$385K	Sell	12,562 -69	-0.5%	-$2.17K	0.01%	241
2015 Q3	$376K	Buy	12,631 +69	+0.5%	+$2.21K	0.01%	232
2015 Q2	$400K	Hold	12,562	–	–	0.01%	238
2015 Q1	$415K	Sell	12,562 -2,635	-17%	-$83.8K	0.01%	234
2014 Q4	$449K	Sell	15,197 -316	-2%	-$9.06K	0.01%	246
2014 Q3	$435K	Sell	15,513 -4,172	-21%	-$117K	0.01%	256
2014 Q2	$554K	Buy	19,685 +2,351	+14%	+$67K	0.01%	245
2014 Q1	$528K	Sell	17,334 -232	-1%	-$6.92K	0.01%	235
2013 Q4	$510K	Buy	17,566 +317	+2%	+$9.23K	0.01%	236
2013 Q3	$470K	Buy	17,249 +19	+0.1%	+$517	0.01%	237
2013 Q2	$458K	Buy	+17,230	New	+$476K	0.01%	236

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Anchor Capital Advisors's PFE Position: Q2 2025 in Review

Anchor Capital Advisors sold out of Pfizer (PFE) in Q2 2025, closing a stake of 9,394 shares — an estimated $238K sold.

Anchor Capital Advisors first reported a position in PFE in Q2 2013 and held it in 48 quarters. The position peaked at $34.4M in Q2 2016. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Anchor Capital Advisors reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Anchor Capital Advisors sold 9,394 Pfizer shares in Q2 2025, an estimated $238K.
Anchor Capital Advisors first reported a position in Pfizer in Q2 2013 and held it in 48 quarters.
Anchor Capital Advisors's Pfizer position peaked at $34.4M in Q2 2016.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Anchor Capital Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.